Media stories about Simulations Plus (NASDAQ:SLP) have trended positive recently, according to AlphaOne. AlphaOne, a unit of Accern, rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. AlphaOne ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Simulations Plus earned a media sentiment score of 0.47 on AlphaOne’s scale. AlphaOne also gave news coverage about the technology company an impact score of 94 out of 100, indicating that recent news coverage is extremely likely to have an effect on the company’s share price in the next few days.
These are some of the news articles that may have impacted AlphaOne Sentiment Analysis’s scoring:
- Simulations Plus : Establishes Distribution Channel in India with Electrolab (4-traders.com)
- Simulations Plus Establishes Distribution Channel in India with Electrolab (finance.yahoo.com)
- 31.4% Return Seen to Date on SmarTrend Simulations Plus Call (SLP) (mysmartrend.com)
- Simulations Plus (SLP) Given Daily News Sentiment Score of 0.62 (americanbankingnews.com)
Shares of Simulations Plus (NASDAQ:SLP) traded up 1.32% during mid-day trading on Friday, reaching $11.55. 39,257 shares of the company were exchanged. Simulations Plus has a 12 month low of $6.74 and a 12 month high of $11.75. The company’s 50 day moving average price is $10.74 and its 200 day moving average price is $9.72. The firm has a market capitalization of $199.12 million, a PE ratio of 37.75 and a beta of -0.17.
Simulations Plus (NASDAQ:SLP) last posted its earnings results on Monday, April 10th. The technology company reported $0.07 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.08 by $0.01. The business earned $5.71 million during the quarter, compared to the consensus estimate of $5.54 million. Simulations Plus had a return on equity of 23.69% and a net margin of 25.33%. Equities analysts anticipate that Simulations Plus will post $0.32 earnings per share for the current year.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.